← Back to Search

Behavioral Intervention

Financial Incentives for Alcoholism

N/A
Recruiting
Research Sponsored by University of North Texas, Denton, TX
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks continuously
Awards & highlights

Study Summary

This trial will test if financial incentives can reduce alcohol use in those who don't respond to traditional treatment methods.

Who is the study for?
This trial is for adults over 21 who frequently drink heavily (more than 8 times in the last month) and want to cut down on drinking. They must be willing to wear a skin alcohol monitor, own a smartphone, and can deposit $20.Check my eligibility
What is being tested?
The study tests an incentive-based program using remote alcohol monitoring and deposit contracts to help reduce heavy drinking among individuals who face barriers accessing traditional treatments.See study design
What are the potential side effects?
There may not be direct physical side effects from participating in this trial as it involves behavioral interventions rather than medications. However, participants might experience stress or discomfort related to altering their drinking habits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks continuously
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks continuously for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Transdermal Alcohol Content

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Deposit Contract GroupExperimental Treatment2 Interventions
Individuals in the Deposit COntract group will be required to put down a 200$ deposit but will earn it back, as well as a bonus, contingently for meeting alcohol reduction requirements. For this study, this is counted as having a Transdermal Alcohol COntent below equal to .02 g/dl. They will be monitored using the Transdermal Alcohol Monitoring device.
Group II: Monitoring Group OnlyActive Control1 Intervention
Individuals in the Monitoring only group will be required to put down a 200$ deposit but will earn it back non-contingently by attending the weekly study meetings. They will be monitored using the Transdermal Alcohol Monitoring device, but will not be required to meet any Alcohol reduction goals to earn their deposit back.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Deposit Contract
2015
N/A
~360

Find a Location

Who is running the clinical trial?

University of North Texas, Denton, TXLead Sponsor
9 Previous Clinical Trials
6,709 Total Patients Enrolled
1 Trials studying Alcoholism
60 Patients Enrolled for Alcoholism
The University of Texas Health Science Center at San AntonioOTHER
453 Previous Clinical Trials
91,350 Total Patients Enrolled
4 Trials studying Alcoholism
332 Patients Enrolled for Alcoholism

Media Library

Deposit Contract (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05837611 — N/A
Alcoholism Research Study Groups: Monitoring Group Only, Deposit Contract Group
Alcoholism Clinical Trial 2023: Deposit Contract Highlights & Side Effects. Trial Name: NCT05837611 — N/A
Deposit Contract (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05837611 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size of individuals participating in this clinical investigation?

"Affirmative. Evidence hosted on clinicaltrials.gov reveals that recruitment for this medical experiment, initially posted on June 10th 2022 and recently updated April 19th 2023, is currently ongoing. The trial requires 80 volunteers to be sourced from a single location."

Answered by AI

Are there presently any opportunities to join this clinical research project?

"As documented on clinicaltrials.gov, the application process for this medical experiment is open to patients. The trial was initially published on June 10th 2022 and most recently revised on April 19th 2023."

Answered by AI
~3 spots leftby May 2024